Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks

World Journal of Clinical Cases ◽

10.12998/wjcc.v9.i18.4690 ◽

2021 ◽

Vol 9 (18) ◽

pp. 4690-4699

Author(s):

Xiao-Fan Chen ◽

Ya-Nan Fan ◽

Chong-Wen Si ◽

Yan-Yan Yu ◽

Jia Shang ◽

...

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Download Full-text

Antiviral activity, dose–response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial

Hepatology International ◽

10.1007/s12072-009-9135-0 ◽

2009 ◽

Vol 3 (3) ◽

pp. 445-452 ◽

Author(s):

Michiko Shindo ◽

Kazuaki Chayama ◽

Satoshi Mochida ◽

Joji Toyota ◽

Eiichi Tomita ◽

...

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Hepatitis B ◽

Antiviral Activity ◽

Chronic Hepatitis B ◽

Dose Response ◽

Response Relationship ◽

Dose Response Relationship ◽

Japanese Adult ◽

Download Full-text

Investigation of therapeutic effect of Longchai Formula Granule on chronic hepatitis B patients: A double-blind, controlled and randomized clinical trial

BIO Web of Conferences ◽

10.1051/bioconf/20170801029 ◽

2017 ◽

Vol 8 ◽

pp. 01029 ◽

Author(s):

Zhanpeng Yan ◽

Tingting Xu ◽

Kelei Su ◽

Chi Wang ◽

Tong Yan ◽

...

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Hepatitis B ◽

Randomized Clinical Trial ◽

Chronic Hepatitis B ◽

Therapeutic Effect ◽

Download Full-text

220 Effects of lamivudine on disease progression and development of liver cancer in advanced chronic hepatitis B: a prospective double-blind placebo-controlled clinical trial

10.1016/s0270-9139(03)80263-x ◽

2003 ◽

Vol 38 ◽

pp. 262-263 ◽

Author(s):

Y LIAW ◽

J SUNG ◽

W CHENCHOW ◽

K SHUE ◽

G FARRELL

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Liver Cancer ◽

Hepatitis B ◽

Disease Progression ◽

Chronic Hepatitis B ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study

The Lancet Gastroenterology & Hepatology ◽

10.1016/s2468-1253(19)30421-2 ◽

2020 ◽

Vol 5 (5) ◽

pp. 441-453 ◽

Author(s):

Pietro Lampertico ◽

Maria Buti ◽

Scott Fung ◽

Sang Hoon Ahn ◽

Wan-Long Chuang ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Phase 3 ◽

Double Blind ◽

Tenofovir Alafenamide

Download Full-text

A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B

Medicine ◽

10.1097/md.0000000000016778 ◽

2019 ◽

Vol 98 (33) ◽

pp. e16778

Author(s):

Rong-Yue Liang ◽

Jing-Hang Xu ◽

Chong-Wen Si ◽

Sa Wang ◽

Jia Shang ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Multicenter Study ◽

Tenofovir Disoproxil Fumarate ◽

Download Full-text

Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial

Journal of Hepatology ◽

10.1016/j.jhep.2019.02.021 ◽

2019 ◽

Vol 71 (1) ◽

pp. 35-44 ◽

Author(s):

Young-Suk Lim ◽

Geum-Youn Gwak ◽

Jonggi Choi ◽

Yung Sang Lee ◽

Kwan Soo Byun ◽

...

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate

Download Full-text

Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.16611 ◽

2021 ◽

Author(s):

Zhihong Liu ◽

Qinglong Jin ◽

Yuexin Zhang ◽

Guozhong Gong ◽

Guicheng Wu ◽

...

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Randomised Clinical Trial

Download Full-text

Faculty Opinions recommendation of Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969434.793470533 ◽

2013 ◽

Author(s):

Cihan Yurdaydin

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate ◽

Follow Up Study

Download Full-text

Reactivation of chronic hepatitis B during treatment with tenofovir disoproxil fumarate: drug interactions or low adherence?: Table 1

BMJ Case Reports ◽

10.1136/bcr-2015-209586 ◽

2015 ◽

pp. bcr2015209586 ◽

Author(s):

Benedetto Caroleo ◽

Orietta Staltari ◽

Luca Gallelli ◽

Francesco Perticone

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Drug Interactions ◽

Chronic Hepatitis B ◽

Tenofovir Disoproxil Fumarate

Download Full-text

Changes in bone mineral density during monotherapy with tenofovir disoproxil fumarate: a 6-year real life longitudinal cohort study in chronic hepatitis B caucasian patients

Digestive and Liver Disease ◽

10.1016/j.dld.2019.12.108 ◽

2020 ◽

Vol 52 ◽

pp. e27

Author(s):

M. Viganò ◽

A. Loglio ◽

F. Cerini ◽

E. Farina ◽

F. Facchetti ◽

...

Keyword(s):

Bone Mineral Density ◽

Chronic Hepatitis ◽

Cohort Study ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Bone Mineral ◽

Tenofovir Disoproxil Fumarate ◽

Real Life ◽

Mineral Density ◽

Caucasian Patients

Download Full-text